Biological Sciences

NEW ORLEANS — Results showed integrating clinical outcomes with laboratory analysis of biological samples may lead to a better understanding of the variable responses to platelet-rich plasma therapy for musculoskeletal conditions.

NEW ORLEANS — Although augmentation of rotator cuff pathology with patches and grafts may play a role in decreasing the retear rate, a presenter said more research is needed to define the best indications and graft source.

NEW ORLEANS — Use of an acellular implant made of aragonite may improve outcomes in patients with early arthritis compared with debridement or microfracture, according to results presented at the Biologic Association Annual Summit.

NEW ORLEANS — In this video, Shane A. Shapiro, MD, discusses characterizing, dosing and investigating therapeutic mechanisms of action of platelet-rich plasma.

NEW ORLEANS — In this video, Kenneth R. Zaslav, MD, provides an update on the accomplishments of the Biologic Association from 2022 to 2023.

NEW ORLEANS — In this video, Brian J. Cole, MD, MBA, FAANA, discusses the possible use of autologous tissue for orthobiologic surgery.

Autologous stromal vascular fraction treatment yielded “acceptable clinical states” in most patients with knee osteoarthritis at 5 years, according to published results.

In this video from the American Academy of Orthopaedic Surgeons Orthobiologics Symposium, Scott A. Rodeo, MD, FAAOS, spoke on the potential of cell and blood-based orthobiologics injectables for patients with osteoarthritis.

According to published results, intra-articular orthobiologics injections are a safe and effective treatment with positive outcomes in patients undergoing high tibial osteotomy for knee osteoarthritis.

In this video from the American Academy of Orthopaedic Surgeons Orthobiologics Symposium, Kenneth R. Zaslav, MD, FAAOS, offered advice on how to integrate the use of orthobiologic injections safely and efficiently into practices.